Market Overview

Benzinga's Top #PreMarket Gainers

Related AGN
Barron's Picks And Pans: Super Chip Stocks, Time Warner And More
Kevin Kelly's Allergan Trade
Gilead NASH Drug 'Active And Promising,' But Lagging Intercept (Investor's Business Daily)
Related TEVA
News Of Clinical Hold For Fasinumab Weighs On Regeneron, Teva Shares
Punishment For This Healthcare ETF Could Create Opportunity
FDA accepts Teva's resubmitted application for deutetrabenazine; action date April 3 (Seeking Alpha)

MediciNova, Inc. (NASDAQ: MNOV) shares climbed 22.51 percent to $4.30 in pre-market trading after the company reported the FDA approval of the second Phase 2 protocol for MN-001 in NASH which targets NASH patients with hypertriglyceridemia.

Allergan PLC (NYSE: AGN) shares rose 8.37 percent to $334.00 in pre-market trading after Teva Pharmaceutical Industries Ltd (ADR) (NYSE: TEVA) announced its plans to buy Allergan's generic drugs unit for $40.5 billion in a cash and stock deal.

Perrigo Company plc Ordinary Shares (NYSE: PRGO) shares rose 4.41 percent to $194.73 in pre-market trading. Perrigo is expected to release Q2 results on August 5, 2015.

Central European Media Enterprises Ltd. (NASDAQ: CETV) shares climbed 4.10 percent to $2.03 in pre-market trading after dropping 0.51 percent on Friday.

Stratasys, Ltd. (NASDAQ: SSYS) gained 2.09 percent to $35.19 in pre-market trading. Dougherty & Company upgraded Stratasys to Buy

Posted-In: PreMarket GainersNews Pre-Market Outlook Markets Movers


Related Articles (CETV + AGN)

View Comments and Join the Discussion!